Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4152273 | 1.00 | CALCRL (0.55) | CALCRLCHRM4 | |
| SCHEMBL6598706 | 0.90 | CALCRL (0.55) | CALCRL | |
| SCHEMBL3962039 | 0.89 | CALCRL (0.58) | CALCRL | |
| SCHEMBL3962041 | 0.89 | CALCRL (0.58) | CALCRL | |
| SCHEMBL3284857 | 0.86 | CALCRL (0.61) | CALCRL | |
| SCHEMBL3278015 | 0.85 | CALCRL (0.55) | CALCRL | |
| SCHEMBL3278724 | 0.84 | CALCRL (0.55) | CALCRL | |
| SCHEMBL3306675 | 0.84 | CALCRL (0.59) | CALCRL | |
| SCHEMBL3307092 | 0.84 | CALCRL (0.59) | CALCRL | |
| SCHEMBL3960433 | 0.84 | CALCRL (0.52) | CALCRLCHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090163480-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | DR. KARL THOMAE GMBH (DE) | 2009-06-25 | — | — | US | disclosed |
| US-20030069231-A1 | Modified aminoacids, pharmaceuticals containing these compounds and method for their production | RUDOLF KLAUS (DE) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163480-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, CHRM1, SRMS | CALCRL 255/4885CHRM4 20/4885 |
| US-20030069231-A1 | Modified aminoacids, pharmaceuticals containing these compounds and method for their production | SLC1A5, NEFM, SRMS | CALCRL 364/4885CHRM4 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.